Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-03

Clinical Trial Update: Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing finasteride to tamsulosin for benign prostatic hyperplasia was terminated with posted results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINASTERIDE (FINASTERIDE)
  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: TERMINATED | Results posted: 2015-12-03